eFFECTOR Therapeutics, Inc.
EFTRDelisted Jul 19, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828522
eFFECTOR Therapeutics, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $251.1K in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding eFFECTOR Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 26 | 33 | +7 |
| Shares | 23.6M | 24.4M | +816.5K (+3.5%) |
| Value | $8.29M | $20.2M | +$11.9M (+143.3%) |
New holders (10)
Institutions that held eFFECTOR Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 81,558 | $67.7K | 0.00% |
| HRT Financial LP | 31,023 | $25.0K | 0.00% |
| XTX Topco Ltd | 28,826 | $23.9K | 0.00% |
| Morgan Stanley | 18,000 | $14.9K | 0.00% |
| Millennium Management LLC | 13,499 | $11.2K | 0.00% |
| Prudential Financial Inc | 13,200 | $11.0K | 0.00% |
| Simplex Trading, LLC | 10,119 | $8.00K | 0.00% |
| Virtu Financial LLC | 10,140 | $8.00K | 0.00% |
| ICA Group Wealth Management, LLC | 1,100 | $914 | 0.00% |
| Royal Bank of Canada | 395 | $0 | 0.00% |
Sold out (3)
Institutions that held eFFECTOR Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Two Sigma Securities, LLC | 24,635 | $8.69K |
| UBS Group AG | 21,414 | $7.56K |
| Ground Swell Capital, LLC | 11,752 | $4.23K |